DIAMOX version 1 clean - Medsafe
action of acetazolamide decreases the secretion of aqueous humour and results in a drop in intraocular pressure, a reaction considered desirable in
Download DIAMOX version 1 clean - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Guidelines for evaluation and management of …
www.bad.org.ukGUIDELINES DOI 10.1111/j.1365-2133.2007.08283.x Guidelines for evaluation and management of urticaria in adults and children C.E.H. Grattan and F. Humphreys* on behalf of the British Association of Dermatologists Therapy Guidelines
Anaphylaxis and anaphylactoid reactions and …
www.conferencematters.co.nzAnaphylaxis and anaphylactoid reactions and allergies Dr Adrian Lim Sydney Skin & Vein Clinic Anaphylaxis/ anaphylactoid reactions Anaphylaxis is a serious, potentially life-threatening reaction that involves multiple
AUSTRALIAN PRODUCT INFORMATION APO- …
www.medicines.org.au1 australian product information – apo- flucloxacillin (flucloxacillin sodium monohydrate) 1 name of the medicine flucloxacillin sodium monohydrate. 2 and 3 qualitative and quantitative composition and
NEW ZEALAND DATA SHEET 1. FLUCLOXACILLIN 2. …
www.medsafe.govt.nzPage 3 of 11 Flucloxacillin is contraindicated in patients with a previous history of flucloxacillin-associated jaundice/hepatic dysfunction.
GUIDELINES FOR MANAGEMENT OF ADVERSE …
www.nzblood.co.nznational 111i01502 guidelines for management of adverse transfusion reactions page 2 of 8 reaction/cause signs & symptoms prevention management
EN-2890 Vancomycin Hydrochloride for Injection, …
www.accessdata.fda.govbacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed.
Related search queries
Guidelines for evaluation and management of, Guidelines for evaluation and management of urticaria, Anaphylaxis and anaphylactoid reactions and, Anaphylaxis, Anaphylactoid reactions Anaphylaxis, Flucloxacillin, GUIDELINES FOR MANAGEMENT OF ADVERSE, Guidelines for management of adverse transfusion reactions, Hydrochloride for Injection,